This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Pertussis (Whooping Cough)
Influenza
Hepatitis B
Haemophilus influenzae Infections
Diphtheria
Tetanus (Lockjaw)
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
PEDIATRICS Vol. 113 No. 1 January 2004, pp. 142-143


POLICY STATEMENT

Recommended Childhood and Adolescent Immunization Schedule—United States, January–June 2004

Committee on Infectious Diseases

Abbreviations: ACIP, Advisory Committee on Immunization Practices • VAERS, Vaccine Adverse Event Reporting System

The annual recommended childhood and adolescent immunization schedule of the American Academy of Pediatrics, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention, and the American Academy of Family Physicians is issued for January to June 2004. A mid-year schedule will be released with any significant new recommendations.

In October 2003, the ACIP recommended universal influenza immunization of all children 6 through 23 months of age and routine influenza immunization of all household contact and out-of-home caregivers of children younger than 24 months. This change by the ACIP from encouraging immunization to recommending immunization currently is under consideration by the Centers for Disease Control and Prevention, American Academy of Family Physicians, and American Academy of Pediatrics for the 2004–2005 influenza season.

Changes in the 2004 schedule include specification of the following minimum ages for the final dose in the vaccine series: 1) diphtheria and tetanus toxoids and acellular pertussis (DTaP), ≥4 years of age; 2) Haemophilus influenzae type b (Hib) conjugate vaccine, ≥12 months of age; 3) pneumococcal conjugate vaccine, ≥12 months of age; and 4) hepatitis B (third or fourth dose), ≥24 weeks of age. The diphtheria and tetanus toxoids (Td) booster is now recommended to be given at 11 to 12 years of age as opposed to 11 to 18 years of age.

Live-attenuated influenza vaccine is an acceptable alternative to the intramuscular trivalent inactivated influenza vaccine for healthy persons 5 to 49 years old. Children ≤8 years of age who are receiving influenza vaccine for the first time should receive 2 doses separated by at least 6 weeks.

Clinically significant adverse events that follow immunization should be reported to the Vaccine Adverse Event Reporting System (VAERS). Guidance about how to obtain and complete a VAERS form can be obtained on the Internet at http://www.vaers.org or by calling 1-800-822-7967. Information on new vaccine releases, vaccine supplies, and statements on specific vaccines can be found at http://www.aap.org and http://www.cdc.gov/nip. Vaccine updates are available in the Red Book1 or online at http://www.aapredbook.org.


    Committee on Infectious Diseases, 2003–2004
 TOP
 Committee on Infectious...
 Liaisons
 Ex Officio
 Consultant
 Staff
 REFERENCES
 
Margaret B. Rennels, MD, Chairperson

Carol J. Baker, MD

Robert S. Baltimore, MD

Joseph A. Bocchini, Jr, MD

Penelope H. Dennehy, MD

Robert W. Frenck, Jr, MD

Caroline B. Hall, MD

Sarah S. Long, MD

Julia A. McMillan, MD

H. Cody Meissner, MD

Keith R. Powell, MD

Lorry G. Rubin, MD

Thomas N. Saari, MD


    Liaisons
 TOP
 Committee on Infectious...
 Liaisons
 Ex Officio
 Consultant
 Staff
 REFERENCES
 
Jack Swanson, MD

Pediatric Practice Action Group

Joanne Embree, MD

Canadian Paediatric Society

Marc A. Fischer, MD

Centers for Disease Control and Prevention

Richard Clover, MD

American Academy of Family Physicians

Bruce Gellin, MD

Centers for Disease Control and Prevention

Mamodikoe Makhene, MD

National Institutes of Health

Walter A. Orenstein, MD

Centers for Disease Control and Prevention

Douglas R. Pratt

Food and Drug Administration

Jeffrey R. Starke, MD

American Thoracic Society


    Ex Officio
 TOP
 Committee on Infectious...
 Liaisons
 Ex Officio
 Consultant
 Staff
 REFERENCES
 
Larry K. Pickering, MD

Red Book Editor


    Consultant
 TOP
 Committee on Infectious...
 Liaisons
 Ex Officio
 Consultant
 Staff
 REFERENCES
 
Edgar O. Ledbetter, MD


    Staff
 TOP
 Committee on Infectious...
 Liaisons
 Ex Officio
 Consultant
 Staff
 REFERENCES
 
Martha Cook, MS


    REFERENCES
 TOP
 Committee on Infectious...
 Liaisons
 Ex Officio
 Consultant
 Staff
 REFERENCES
 

  1. American Academy of Pediatrics, Committee on Infectious Diseases. In Pickering LK, Ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th Ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003. Available at: http://www.aapredbook.org

PEDIATRICS (ISSN 1098-4275). ©2004 by the American Academy of Pediatrics

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

The following policy statement is a revision:

Recommended Childhood and Adolescent Immunization Schedule--United States, July-December 2004

Pediatrics 113: 1448-1448. [Full Text]

The following policy statement has been revised:

Recommended Childhood and Adolescent Immunization Schedule--United States, 2003

Pediatrics 111: 212-216. [Full Text]



This article has been cited by other articles:


Home page
PediatricsHome page
Committee on Child Health Financing
Scope of Health Care Benefits for Children From Birth Through Age 21
Pediatrics, March 1, 2006; 117(3): 979 - 982.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
H. F. Smitherman, A. C. Caviness, and C. G. Macias
Retrospective Review of Serious Bacterial Infections in Infants Who Are 0 to 36 Months of Age and Have Influenza A Infection
Pediatrics, March 1, 2005; 115(3): 710 - 718.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
Committee on Fetus and Newborn
Hospital Stay for Healthy Term Newborns
Pediatrics, May 1, 2004; 113(5): 1434 - 1436.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Pertussis (Whooping Cough)
Influenza
Hepatitis B
Haemophilus influenzae Infections
Diphtheria
Tetanus (Lockjaw)
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?